News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases Michael O'Riordan August 16, 2018
News Daily News Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days Michael O'Riordan July 19, 2018
News Daily News ‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes Yael L. Maxwell June 29, 2018
News Daily News PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations Michael O'Riordan May 10, 2018
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018
News Daily News LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR Yael L. Maxwell March 01, 2018